✦ LIBER ✦

PDB4 MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETES

✍ Scribed by J.A. Gaebler; G. Soto-Campos; P.E. Alperin; B.J. Hoogwerf; M. Wintle; D. Maggs; J. Han; A. Blickensderfer; R. Pencek; D. Bruhn; B.R. Peskin

Book ID: 119309284
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 58 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.02.512

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB14 USING HEALTH OUTCOMES MODELING TO

PDB14 USING HEALTH OUTCOMES MODELING TO ASSESS THE BENEFIT-RISK PROFILE OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR PATIENTS WITH TYPE-2 DIABETES

✍ L. Garrison; J.H. Best; J.C. Robertson; M. Wenten; D. Bruhn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PDB9 LONG-TERM CLINICAL OUTCOMES OF EXEN

PDB9 LONG-TERM CLINICAL OUTCOMES OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR THE TREATMENT OF TYPE 2 DIABETES PROJECTED USING THE CORE DIABETES MODEL

✍ L Timlin; A Beaudet; B Wilson; D Bruhn; KS Boye; JL Palmer; A Lloyd 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PDB26 Projected Long-Term Clinical and E

PDB26 Projected Long-Term Clinical and Economic Outcomes of Exenatide Once Weekly Versus Sitagliptin for the Treatment of Type 2 Diabetes in the UK

✍ Beaudet, A.; Wilson, B.; Caputo, J.; Timlin, L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PDB51 COST-EFFECTIVENESS OF EXENATIDE VE

PDB51 COST-EFFECTIVENESS OF EXENATIDE VERSUS INSULIN GLARGINE AND VERSUS BIPHASIC INSULIN ASPART FOR THE TREATMENT OF TYPE 2 DIABETES IN PORTUGAL: A LONG-TERM HEALTH ECONOMIC ANALYSIS

✍ JL Palmer; CG Pinto; R Duarte; L Miguel; Z Gregor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Efficacy and safety of exenatide once we

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

✍ Richard M Bergenstal; Carol Wysham; Leigh MacConell; Jaret Malloy; Brandon Walsh 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 399 KB

Treatment of patients with type 2 diabet

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals

✍ Alison R Meloni, Mary Beth DeYoung, Jenny Han, Jennie H Best… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 246 KB